Matthias Druner
Emden, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnostic performance of β-(1→3)-D-glucan, two Candida antigen, and five anti-Candida antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial.
Journal: Journal of clinical microbiology
Published: April 23, 2026
Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock.
Journal: Journal of clinical medicine
Published: November 30, 2023
(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Journal: Intensive care medicine
Published: February 20, 2022
Reply to Supady et al. On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on "Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J. Clin. Med. 2021, 10, 2939".
Journal: Journal of clinical medicine
Published: September 14, 2021
First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock.
Journal: Journal of clinical medicine
Published: June 01, 2021
Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial.
Journal: The Lancet. Respiratory medicine
Published: May 21, 2021
Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series.
Journal: Journal of the Intensive Care Society
Published: June 04, 2020
Hemoadsorption by CytoSorb in septic patients: a case series.
Journal: Critical care (London, England)
Published: January 17, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026